Figure 1. . Kaplan-Meier plot of overall survival for patients with stable, treated brain metastases in the BEACON Phase III trial.

EP: Etirinotecan pegol; HR: Hazard ratio; OS: Overall survival; TPC: Treatment of physician's choice.
Created using data from Shah et al. [54].